A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

NCT02533401 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphocytic Leukemia, Chronic

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab

Sponsor

Hoffmann-La Roche